- Type / Class
- Equity / Common Stock
- Shares outstanding
- 353,007,843
- Total 13F shares
- 82,070,744
- Share change
- +1,882,256
- Total reported value
- $116,553,437
- Put/Call ratio
- 196%
- Price per share
- $1.42
- Number of holders
- 146
- Value change
- +$2,653,090
- Number of buys
- 68
- Number of sells
- 45
Quarterly Holders Quick Answers
What is CUSIP 74017N105?
CUSIP 74017N105 identifies PGEN - PRECIGEN, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74017N105:
Top shareholders of PGEN - PRECIGEN, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| William H. Miller III |
13D/G
|
William H. Miller III Living Trust dated April 17, 2017 |
9.2%
|
34,051,925
|
$154,936,259 | $0 | 26 Jun 2025 | |
| Ares Trading S.A. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
20,647,152
|
$29,112,484 | — | 12 Oct 2021 | |
| Patient Capital Management, LLC |
13F
|
Company |
4.9%
|
17,372,301
|
$25,884,728 | — | 31 Mar 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
3.2%
|
11,276,000
|
$16,801,240 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
3%
|
10,752,215
|
$16,020,799 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.5%
|
8,795,959
|
$13,105,979 | — | 31 Mar 2025 | |
| IRIDIAN ASSET MANAGEMENT LLC/CT |
13F
|
Company |
1.3%
|
4,585,809
|
$6,832,855 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.05%
|
184,868
|
$5,203,379 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.99%
|
3,479,602
|
$5,186,056 | — | 31 Mar 2025 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.9%
|
3,191,343
|
$4,755,101 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.86%
|
3,038,127
|
$4,526,809 | — | 31 Mar 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.79%
|
2,794,249
|
$4,163,430 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.34%
|
1,216,764
|
$1,812,978 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.32%
|
1,126,576
|
$1,678,598 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.29%
|
1,033,110
|
$1,539,334 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.23%
|
813,310
|
$1,211,832 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.22%
|
792,803
|
$1,181,276 | — | 31 Mar 2025 | |
| Corient Private Wealth LLC |
13F
|
Company |
0.2%
|
714,691
|
$1,064,891 | — | 31 Mar 2025 | |
| LexAurum Advisors, LLC |
13F
|
Company |
0.19%
|
685,298
|
$1,021,094 | — | 31 Mar 2025 | |
| GMT CAPITAL CORP |
13F
|
Company |
0.19%
|
668,830
|
$996,557 | — | 31 Mar 2025 | |
| Dean J. Mitchell |
3/4/5
|
Director |
—
mixed-class rows
|
692,221
mixed-class rows
|
$844,551 | — | 14 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.15%
|
512,307
|
$763,337 | — | 31 Mar 2025 | |
| Robert B. Shapiro |
3/4/5
|
Director |
—
mixed-class rows
|
596,438
mixed-class rows
|
$657,116 | — | 09 Mar 2023 | |
| Jeffrey Thomas Perez |
3/4/5
|
SVP, IP Affairs |
—
mixed-class rows
|
1,043,097
mixed-class rows
|
$631,632 | — | 09 Aug 2024 | |
| Fore Capital, LLC |
13F
|
Company |
0.11%
|
391,811
|
$583,798 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.09%
|
333,512
|
$496,932 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.09%
|
331,942
|
$494,593 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
0.09%
|
317,141
|
$472,539 | — | 31 Mar 2025 | |
| Cetera Investment Advisers |
13F
|
Company |
0.08%
|
284,062
|
$423,252 | — | 31 Mar 2025 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0.09%
|
331,476
|
$387,827 | — | 31 Mar 2025 | |
| Mill Creek Capital Advisors, LLC |
13F
|
Company |
0.07%
|
255,000
|
$379,950 | — | 31 Mar 2025 | |
| Inspire Investing, LLC |
13F
|
Company |
0.07%
|
235,112
|
$350,317 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.07%
|
232,347
|
$346,196 | — | 31 Mar 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.06%
|
226,660
|
$337,723 | — | 31 Mar 2025 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.06%
|
205,186
|
$305,727 | — | 31 Mar 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.06%
|
194,493
|
$289,778 | — | 31 Mar 2025 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.05%
|
191,719
|
$286,000 | — | 31 Mar 2025 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.05%
|
191,852
|
$285,859 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.05%
|
191,037
|
$284,633 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.05%
|
179,835
|
$267,953 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.05%
|
164,458
|
$245,042 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.04%
|
146,456
|
$218,219 | — | 31 Mar 2025 | |
| INTECH INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.03%
|
117,909
|
$175,684 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.03%
|
97,872
|
$145,830 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.03%
|
91,031
|
$135,636 | — | 31 Mar 2025 | |
| CARY STREET PARTNERS FINANCIAL LLC |
13F
|
Company |
0.02%
|
87,593
|
$130,514 | — | 31 Mar 2025 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.02%
|
83,181
|
$123,940 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.02%
|
81,700
|
$121,733 | — | 31 Mar 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.02%
|
81,610
|
$121,599 | — | 31 Mar 2025 | |
| EXCHANGE TRADED CONCEPTS, LLC |
13F
|
Company |
0.02%
|
71,566
|
$106,633 | — | 31 Mar 2025 |
Institutional Holders of PRECIGEN, INC. - Common Stock (PGEN) as of Q2 2025
As of 30 Jun 2025,
PRECIGEN, INC. - Common Stock (PGEN) was held by
146 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
82,070,744 shares.
The largest 10 holders included
Patient Capital Management, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock, Inc., VANGUARD GROUP INC, IRIDIAN ASSET MANAGEMENT LLC/CT, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, MORGAN STANLEY, Parkman Healthcare Partners LLC, and Schonfeld Strategic Advisors LLC.
This page lists
147
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
137
Q2 2025 holders
146
Holder diff
9
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.